248 related articles for article (PubMed ID: 35056081)
1. The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis.
Morris R; Butler L; Perkins A; Kershaw NJ; Babon JJ
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056081
[TBL] [Abstract][Full Text] [Related]
2. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.
Oh ST; Simonds EF; Jones C; Hale MB; Goltsev Y; Gibbs KD; Merker JD; Zehnder JL; Nolan GP; Gotlib J
Blood; 2010 Aug; 116(6):988-92. PubMed ID: 20404132
[TBL] [Abstract][Full Text] [Related]
3. [Role of LNK gene mutation in pathogenesis of myeloproliferative neoplasms-review].
Chen Y; Wu XQ; Han CS; Zhu P; Wei JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1309-12. PubMed ID: 24156456
[TBL] [Abstract][Full Text] [Related]
4. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling.
Devallière J; Charreau B
Biochem Pharmacol; 2011 Nov; 82(10):1391-402. PubMed ID: 21723852
[TBL] [Abstract][Full Text] [Related]
5. When the Brakes are Lost: LNK Dysfunction in Mice, Men, and Myeloproliferative Neoplasms.
Oh ST
Ther Adv Hematol; 2011 Feb; 2(1):11-9. PubMed ID: 23556072
[TBL] [Abstract][Full Text] [Related]
6. Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer.
López-Mejía JA; Mantilla-Ollarves JC; Rocha-Zavaleta L
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834225
[TBL] [Abstract][Full Text] [Related]
7. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.
Maslah N; Cassinat B; Verger E; Kiladjian JJ; Velazquez L
Leukemia; 2017 Aug; 31(8):1661-1670. PubMed ID: 28484264
[TBL] [Abstract][Full Text] [Related]
8. An insight into JAK-STAT signalling in dermatology.
Palanivel JA; Macbeth AE; Chetty NC; Levell NJ
Clin Exp Dermatol; 2014 Jun; 39(4):513-8. PubMed ID: 24825142
[TBL] [Abstract][Full Text] [Related]
9. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
[TBL] [Abstract][Full Text] [Related]
10. LNK/
Wintering A; Hecht A; Meyer J; Wong EB; Hübner J; Abelson S; Feldman K; Kennedy VE; Peretz CAC; French DL; Maguire JA; Jobaliya C; Vasquez MR; Desai S; Dulman R; Nemecek E; Haines H; Hammad M; El Haddad A; Kogan SC; Abdullaev Z; Chehab FF; Tasian SK; Smith CC; Loh ML; Stieglitz E
Haematologica; 2023 Dec; ():. PubMed ID: 38152053
[TBL] [Abstract][Full Text] [Related]
11. Gα73B is a downstream effector of JAK/STAT signalling and a regulator of Rho1 in Drosophila haematopoiesis.
Bausek N; Zeidler MP
J Cell Sci; 2014 Jan; 127(Pt 1):101-10. PubMed ID: 24163435
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional analysis of target recognition by the lymphocyte adaptor protein LNK.
Morris R; Zhang Y; Ellyard JI; Vinuesa CG; Murphy JM; Laktyushin A; Kershaw NJ; Babon JJ
Nat Commun; 2021 Oct; 12(1):6110. PubMed ID: 34671038
[TBL] [Abstract][Full Text] [Related]
13. Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency.
Dou H; Kotini A; Liu W; Fidler T; Endo-Umeda K; Sun X; Olszewska M; Xiao T; Abramowicz S; Yalcinkaya M; Hardaway B; Tsimikas S; Que X; Bick A; Emdin C; Natarajan P; Papapetrou EP; Witztum JL; Wang N; Tall AR
Circulation; 2021 Dec; 144(24):1940-1954. PubMed ID: 34846914
[TBL] [Abstract][Full Text] [Related]
14. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
Heim MH
J Recept Signal Transduct Res; 1999; 19(1-4):75-120. PubMed ID: 10071751
[TBL] [Abstract][Full Text] [Related]
15. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease.
Durham GA; Williams JJL; Nasim MT; Palmer TM
Trends Pharmacol Sci; 2019 May; 40(5):298-308. PubMed ID: 30948191
[TBL] [Abstract][Full Text] [Related]
16. A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms.
Beghini A; Leuzzi L; Abazari N; Bossi LE; Guido V; Trojani A; Cairoli R
Hematol Oncol; 2022 Dec; 40(5):1109-1112. PubMed ID: 35570682
[TBL] [Abstract][Full Text] [Related]
17. The molecular details of cytokine signaling via the JAK/STAT pathway.
Morris R; Kershaw NJ; Babon JJ
Protein Sci; 2018 Dec; 27(12):1984-2009. PubMed ID: 30267440
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.
Migita K; Izumi Y; Torigoshi T; Satomura K; Izumi M; Nishino Y; Jiuchi Y; Nakamura M; Kozuru H; Nonaka F; Eguchi K; Kawakami A; Motokawa S
Clin Exp Immunol; 2013 Dec; 174(3):356-63. PubMed ID: 23968543
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and non-canonical aspects of JAK/STAT signalling.
Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
[TBL] [Abstract][Full Text] [Related]
20. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours.
Thomas SJ; Snowden JA; Zeidler MP; Danson SJ
Br J Cancer; 2015 Jul; 113(3):365-71. PubMed ID: 26151455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
